Generic Equivalent of Norvasc Launches
March 28, 2007
On Friday, March 23rd, Mylan Pharmaceuticals began shipments of
FDA-approved amlodipine besylate tablets, the AB rated generic
equivalent of Pfizer’s blockbuster Norvasc. The product was launched in
the 2.5mg, 5mg, and 10mg strengths, each in 90 count bottles. The 500
count bottles were not available at launch; however they are anticipated
to be available shortly thereafter.
Norvasc is a calcium channel blocker, licensed for the treatment of high
blood pressure, certain types of chest pain, and coronary artery
disease. U.S. sales of all strengths of Norvasc were approximately $2.3
billion last year.
(Via McKesson)
Comments
Got something to say?
Powered by WordPress
